The short version of peptide research fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-11-16. Anything still debated is marked as such rather than presented as settled.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
==== Cruise ship terminal ==== Conversion and restoration of the historic former Dover Marine rail terminus, and the opening of a second, larger, cruise terminal building in 1996, have supported a significant expansion in cruise ship traffic. Cruise Terminal 2 is able to accommodate ships as large as the Celebrity Silhouette at 319 metres (1,047 ft) in length overall, a beam of 36.8 metres (121 ft) and 122,400 gross tons. The cruise ship terminal can accommodate up to three ships at any one time. In 2019 the Port of Dover accommodated 130 cruise ship port calls and over 200,000 passengers, making it the second busiest cruise ship port in the United Kingdom after the Port of Southampton.
=== Religious use === Use of DET by Alan Birnbaum played an important role in the development and beliefs of his psychedelic church The Temple of the True Inner Light, which subsequently employed the unscheduled and hence dipropyltryptamine (DPT) as well as other psychedelics as sacraments.
Ground birch bark, fermented in sea water, is used for seasoning the woolen, hemp or linen sails and hemp rope of traditional Norwegian boats. Birch twigs bound in a bundle, also called birch, were used for birching, a form of corporal punishment. Many Native Americans in the United States and Indigenous peoples in Canada prize the birch for its bark, which because of its light weight, flexibility, and the ease with which it can be stripped from fallen trees, is often used for the construction of strong, waterproof but lightweight canoes, bowls, and wigwams. The Hughes H-4 Hercules was made mostly of birch wood, despite its better-known moniker, "The Spruce Goose". Birch plywood was specified by the BBC as the only wood that can be used in making the cabinets of the long-lived LS3/5A loudspeaker. Birch is used as firewood because of its high calorific value per unit weight and unit volume. It burns well, without popping, even when frozen, or freshly hewn. The bark will burn very well even when wet because of the oils it contains. With care, it can be split into very thin sheets that will ignite from even the smallest of sparks. Birch wood can be used to smoke foods. Birch seeds are used as leaf litter in miniature terrain models. Birch oil is used in the manufacture of Russia leather, a water-resistant leather.
== Isoforms == Different isoforms of retinal dehydrogenase exist and play a key role in development, as the types are differentially expressed inside a developing embryo. The enzyme retinal dehydrogenase type-2 (ALDH1A2 or RALDH2) catalyzes much of the retinoic acid formation during development, but not all. ALDH1A2 is crucial for development midgestation and helps drive neural, heart, lung, and forelimb development; it is also responsible for all retinoic acid development during certain periods of midgestation. Later in development, retinal dehydrogenase type-1 (ALDH1A1 or RALDH1) begins activity in the dorsal pit of the retina and retinal dehydrogenase type-3 (ALDH1A3 or RALDH3) becomes active in the olfactory pit, ventral retina, and urinary tract. ALDH1A2 gene knockouts are fatal in mice during development since the brain cannot develop normally. ALDH1A3 gene knockout is fatal at birth in mice since nasal passages are not properly developed and instead are blocked. ALDH1A1 knockouts are not fatal and, interestingly, have been shown to be protective against diet-induced obesity in mice in a retinoid-independent manner.
King Michał Korybut Wiśniowiecki, a native Pole, was elected to replace John II Casimir in 1669. The Polish–Ottoman War (1672–1676) broke out during his reign, which lasted until 1673, and continued under his successor, John III Sobieski (r. 1674–1696). Sobieski intended to pursue Baltic area expansion (and to this end he signed the secret Treaty of Jaworów with France in 1675), but was forced instead to fight protracted wars with the Ottoman Empire. By doing so, Sobieski briefly revived the Commonwealth's military might. He defeated the expanding Muslims at the Battle of Khotyn in 1673 and decisively helped deliver Vienna from a Turkish onslaught at the Battle of Vienna in 1683. Sobieski's reign marked the last high point in the history of the Commonwealth: in the first half of the 18th century, Poland ceased to be an active player in international politics. The Treaty of Perpetual Peace (1686) with Russia was the final border settlement between the two countries before the First Partition of Poland in 1772. The Commonwealth, subjected to almost constant warfare until 1720, suffered enormous population losses and massive damage to its economy and social structure. The government became ineffective in the wake of large-scale internal conflicts, corrupted legislative processes and manipulation by foreign interests. The nobility fell under the control of a handful of feuding magnate families with established territorial domains.
Sources: en.wikipedia.org
Europe has known almost as much peace as war; and it has owed these periods of peace to the Balance of Power. No one state has ever been strong enough to eat up all the rest, and the mutual jealousy of the Great Powers has preserved even the small states, which could not have preserved themselves.
==== Netherlands ==== In the Netherlands, 2C-B was scheduled on July 9, 1997. In the Netherlands, 2C-B became a list I substance of the Opium Law despite no health incidents occurring. Following the ban, other phenethylamines were sold in place of 2C-B until the Netherlands became the first country in the world to ban 2C-I, 2C-T-2 and 2C-T-7 alongside 2C-B.
There are numerous theories as to the exact cause and mechanism in type 2 diabetes. Central obesity is known to predispose individuals for insulin resistance. Abdominal fat is especially active hormonally, secreting a group of hormones called adipokines that may possibly impair glucose tolerance. But adiponectin, an anti-inflammatory adipokine, which is found in lower concentration in obese and diabetic individuals has shown to be beneficial and protective in type 2 diabetes mellitus (T2DM). Insulin resistance is a major feature of diabetes mellitus type 2, and central obesity is correlated with both insulin resistance and T2DM itself. Increased adiposity (obesity) raises serum resistin levels, which in turn directly correlate to insulin resistance. Studies have also confirmed a direct correlation between resistin levels and T2DM. And it is waistline adipose tissue (central obesity) which seems to be the foremost type of fat deposits contributing to rising levels of serum resistin. Conversely, serum resistin levels have been found to decline with decreased adiposity following medical treatment.
=== Chalcogenides, pnictides, and carbides === Neptunium chalcogen and pnictogen compounds have been well studied primarily as part of research into their electronic and magnetic properties and their interactions in the natural environment. Pnictide and carbide compounds have also attracted interest because of their presence in the fuel of several advanced nuclear reactor designs, although the latter group has not had nearly as much research as the former.
In another one-pot multicomponent reaction, a unique two-carbon expansion has been achieved by reacting isatin with indene-1,3-dione and N-substituted pyridinium bromide to form dibenzo[b,d]azepin-6-ones.
Sources: en.wikipedia.org
=== Duplication === Sometimes backups are duplicated to a second set of storage media. This can be done to rearrange the archive files to optimize restore speed, or to have a second copy at a different location or on a different storage medium—as in the disk-to-disk-to-tape capability of Enterprise client-server backup.
Benzene targets the liver, kidney, lung, heart and brain and can cause DNA strand breaks and chromosomal damage, therefore it is mutagenic. Benzene causes cancer in animals including humans. Benzene has been shown to cause cancer in both sexes of multiple species of laboratory animals exposed via various routes.
Polymer-based nanoparticles can be made from either natural or synthetic sources. Nanospheres and nanocapsules are polymeric nanoparticle systems. Natural polymers can be found in the environment or human body. On the other hand, synthetic polymers do not occur naturally and are artificially developed polymers with chemical modifications. Natural polymer-based nanoparticles can be made up of chitosan, hyaluronic acid, alginate, and gelatin. Natural polymers exhibit excellent biocompatibility and biodegradability, and low toxicity. Synthetic polymer-based nanoparticles can consist of polyglycolic acid (PGA), poly (lactic acid) (PLA), and poly(lactide-co-glycolide) (PLGA). A study evaluated chitosan nanoparticles loaded with an anti-epileptic drug, phenytoin (PHT), to treat epilepsy. Observations suggested high stability, sustained release, and bioavailability when these particles where administered via the intranasal route. Similarly, administering PLGA nanoparticles loaded lamotrigine (LTG), polymer-based nanoparticle, showed better permeation through BBB and higher bioavailability.
at the upper end of the tube. At excess temperatures above that at the minimum heat flux, the contribution of radiation becomes appreciable, and it becomes dominant at high excess temperatures. The total heat transfer coefficient is thus a combination of the two. Bromley has suggested the following equations for film boiling from the outer surface of horizontal tubes:
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.